Apogee Therapeutics, Inc. Share Price
APGEApogee Therapeutics, Inc. Stock Performance
Open $57.13 | Prev. Close $63.47 | Circuit Range N/A |
Day Range $57.13 - $63.80 | Year Range $26.29 - $63.80 | Volume 62,028 |
Average Traded $62.21 |
Apogee Therapeutics, Inc. Share Price Chart
About Apogee Therapeutics, Inc.
Apogee Therapeutics, Inc., a clinical stage biotechnology company, develops novel biologics for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other inflammatory and immunology indications. The company develops APG777, a subcutaneous (SQ) extended half-life monoclonal antibody (mAb) for the treatment of AD, which is in phase 2 clinical trials; and for the treatment of asthma and EoE which is in phase 1 clinical trial. It also develops APG279 that is in preclinical stage for the treatment of AD; APG990, an SQ extended half-life mAb for the treatment of AD; APG333, a human mAb against thymic stromal lymphopoietin for the treatment of asthma and COPD; and APG808, an SQ extended half-life mAb targeting IL-4Ra for the treatment of Type 2 allergic diseases. Apogee Therapeutics, Inc. was incorporated in 2022 and is headquartered in Waltham, Massachusetts.
Apogee Therapeutics, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
11-Nov-25 | $57.13 | $62.88 | +0.00% |
11-Nov-25 | $57.13 | $62.88 | +10.78% |
10-Nov-25 | $56.31 | $56.77 | +3.72% |
07-Nov-25 | $55.18 | $54.73 | -0.55% |
06-Nov-25 | $55.30 | $55.03 | -0.83% |
05-Nov-25 | $53.45 | $55.49 | +2.89% |
04-Nov-25 | $54.17 | $53.93 | -0.86% |
FAQs on Apogee Therapeutics, Inc. Share Price
Can I buy Apogee Therapeutics, Inc. shares in India?
What is the share price of Apogee Therapeutics, Inc.?
What is the 5 year returns of Apogee Therapeutics, Inc.?
What are the high & low stock price of Apogee Therapeutics, Inc. today?
What is the 52-week high and low of Apogee Therapeutics, Inc. stock?